What percent of BVAXF is sold short?

44.3% of BioVaxys (BVAXF) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is BVAXF a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for BioVaxys (BVAXF).

BVAXF Short Volume Hit 44.3%

Also trades as: BIOV.CN (CNQ) · $vol 0M

$0.09

+0.00 (+0.95%)

Weekly Expected Move ±49.2%

$0 $0 $0 $0 $0

OTC · Healthcare · Biotechnology · Tech Score Sell · Power 45 · $2.5M mcap · 26M float · 0.085% daily turnover · Short 35% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Short Volume Summary

2026-10-01

48.0%

Short Ratio

of total volume

36.0%

20-Day Avg

39.6%

50-Day Avg

▲ Rising

5-Day Trend

0.0M

Short Volume

0.0M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
O	9,380	19,545	48.0%

BVAXF Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet